Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update (Q37989844)

26 August 2017

title

Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update (English)

1 reference

26 August 2017

author name string

Neife Aparecida Guinaim dos Santos

1

1 reference

26 August 2017

Maria Augusta Carvalho Rodrigues

2

1 reference

26 August 2017

Nadia Maria Martins

3

1 reference

26 August 2017

Antonio Cardozo dos Santos

4

1 reference

26 August 2017

language of work or name

1 reference

1 March 2012

1 reference

26 August 2017

published in

Archives of Toxicology

1 reference

26 August 2017

volume

86

1 reference

26 August 2017

issue

8

1 reference

26 August 2017

page(s)

1233-1250

1 reference

Life-or-death decisions by the Bcl-2 protein family.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Co-supplementation of single and multi doses of vitamins C and E ameliorates cisplatin-induced acute renal failure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Naringenin attenuates cisplatin nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

alpha-Lipoic acid prevents cisplatin-induced acute kidney injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Differential roles of hydrogen peroxide and hydroxyl radical in cisplatin-induced cell death in renal proximal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

21 January 2018

Nuclear factor-kappa B.

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role of apoptosis in the pathogenesis of acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

BNP7787, a novel protector against platinum-related toxicities, does not affect the efficacy of cisplatin or carboplatin in human tumour xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Drug transporters of platinum-based anticancer agents and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

The p53 pathway and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Update on malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Tumor necrosis factor-alpha induces intrinsic apoptotic signaling during renal obstruction through truncated bid activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Radiosensitizers in cervical cancer. Cisplatin and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Oxidative stress, toxicology, and pharmacology of CYP2E1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

L-Carnitine inhibits cisplatin-induced injury of the kidney and small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin: from DNA damage to cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Nephrotoxicity and hydration management for cisplatin, carboplatin, and ormaplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role of an endoplasmic reticulum Ca2+-independent phospholipase A2 in cisplatin-induced renal cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Protective effects of increasing vitamin E and a doses on cisplatin-induced oxidative damage to kidney tissue in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Resveratrol attenuates cisplatin-induced nephrotoxicity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Inhibitors of histone deacetylases suppress cisplatin-induced p53 activation and apoptosis in renal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Effect of platelet-activating factor antagonist BN 52063 on the nephrotoxicity of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Influence of hydration on ultrafilterable platinum kinetics and kidney function in patients treated with cis-diamminedichloroplatinum(II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Ischemic kidney injury and mechanisms of tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Caspase-2 permeabilizes the outer mitochondrial membrane and disrupts the binding of cytochrome c to anionic phospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Caspase-1-deficient mice are protected against cisplatin-induced apoptosis and acute tubular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Protective effect of quercetin on the evolution of cisplatin-induced acute tubular necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cellular accumulation of the anticancer agent cisplatin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Minireview. The nephrotoxicity of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Functional TauT protects against acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Stress response inhibits the nephrotoxicity of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Accumulation of BNP7787 in human renal proximal tubule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Effect of aminophylline on cisplatin nephrotoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Edaravone inhibits acute renal injury and cyst formation in cisplatin-treated rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Chemotherapy in advanced bladder cancer: current status and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Thrombotic Microangiopathy and Renal Failure Associated with Antineoplastic Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Amelioration of cisplatin nephrotoxicity by genetic or pharmacologic blockade of prostaglandin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Regulation and pathological role of p53 in cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Regulation of PUMA-alpha by p53 in cisplatin-induced renal cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cell apoptosis and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

The effects of desferrioxamine on cisplatin-induced lipid peroxidation and the activities of antioxidant enzymes in rat kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Protecting cisplatin-induced nephrotoxicity with cimetidine does not affect antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Anticancer drug-induced kidney disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Rosiglitazone ameliorates cisplatin-induced renal injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Pituitary adenylate cyclase-activating polypeptide ameliorates cisplatin-induced acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Potential role of platelet activating factor in acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Nephrotoxicity of platinum complexes is related to basolateral organic cation transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

The role of oxygen free radicals in cisplatin-induced acute renal failure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

DNA damage-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Carvedilol protects against the renal mitochondrial toxicity induced by cisplatin in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Carvedilol protects against cisplatin-induced oxidative stress, redox state unbalance and apoptosis in rat kidney mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Fundamental studies with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Platinum Compounds: a New Class of Potent Antitumour Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Protective effects of the angiotensin II receptor blocker losartan on cisplatin-induced kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

A novel free radical scavenger, edarabone, protects against cisplatin-induced acute renal damage in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

From finch to fish to man: role of aquaporins in body fluid and brain water regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Ctr1 and its role in body copper homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Antioxidant properties of amidothionophosphates: novel antioxidant molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Mitochondrial formation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Apoptotic mechanisms in acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

TRAIL and apoptosis induction by TNF-family death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cellular processing of platinum anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Activation and involvement of p53 in cisplatin-induced nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Nephrotoxicity of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Enhancement of lexatumumab-induced apoptosis in human solid cancer cells by Cisplatin in caspase-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin preferentially binds mitochondrial DNA and voltage-dependent anion channel protein in the mitochondrial membrane of head and neck squamous cell carcinoma: possible role in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Cisplatin nephrotoxicity: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

Role of CysteineS-Conjugate β-Lyase in the Metabolism of Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00204-012-0821-7

10.1007/S00204-012-0821-7

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference